Pa. Appeals Court Asked To Lift Cap On Risperdal Damages

Law360, Philadelphia (July 25, 2017, 5:51 PM EDT) -- The application of a New Jersey law limiting the availability of punitive damages against drugmakers unfairly curbed a Maryland man’s potential recovery from a Johnson & Johnson unit in a case over breast growth attributed to the antipsychotic drug Risperdal, a Pennsylvania appeals court heard during oral arguments on Tuesday.

Kline & Specter PC attorney Chip Becker argued that plaintiff Nicholas Murray was left holding the short end of the stick after being subjected to both a cap on noneconomic damages under Maryland law and an order entered under New Jersey law preventing Janssen Pharmaceuticals Inc. from facing punitive damages in...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!